To report the incidence of massive fetomaternal hemorrhage (FMH) associated with fetal death and to test the hypothesis that FMH is more likely to occur in those with risk factors for FMH.
Fetal death has been associated with massive fetomaternal hemorrhage (FMH) in both case reports and in several small series. [1] [2] [3] [4] [5] Fewer than 100 cases have been reported in which a specific assay for FMH, the Betke-Kleihauer (BK) test, was performed to determine the cause of fetal death. Due to the small number of cases reported, the prevalence of massive FMH when fetal death occurs is uncertain. It has not been possible to determine whether or not conditions that increase the risk for FMH actually increase the likelihood that FMH is present as a cause for fetal demise.
The purpose of this study is to report the incidence of massive FMH in a large cohort of fetal deaths. The secondary purpose is to test the hypothesis that massive FMH is more likely to occur among patients with traditionally known risk factors for FMH than those without these risk factors.
MATERIALS AND METHODS
All cases of fetal death during the period between January 1, 1990 and December 31, 1994 evaluated at the Los Angeles County/University of Southern California Medical Center were reviewed. During this time period the BK test was ordered as part of the evaluation for fetal death at the discretion of the attending physician. The maternal and fetal charts for each stillbirth were reviewed at the end of each month. A clinical summary of each case was recorded. The results of the tests performed for the evaluation of fetal death, including autopsy and the pathologic examination of the placenta, if performed, were reviewed by a research nurse and recorded in a database.
We divided the fetal deaths in which the BK test was performed Original Article
into two groups based on the presence or absence of traditionally accepted risk factors for FMH. Risk factors for FMH include hypertension disorders of pregnancy, hydrops fetalis, abruptio placentae, trauma, substance (cocaine) abuse, twin-twin transfusion syndrome, unexplained elevated maternal serum Alpha-fetoprotein, and selected placental pathologic findings (placental infarction, obliterative vasculopathy, and placentomegaly). Cases of elective termination and/or birth weight Ͻ500 gm were excluded. The BK stain was done in our laboratory using automated red blood cell counting of the initial specimen and delivery of a standard volume (1 l) of a standard dilution (1:1000) in the form of a droplet on a microscope slide. Cell counting was done using the Miller disk. The amount of hemorrhage is expressed as the number of fetal cells per maternal cells observed (e.g., 0.1% ϭ 1 fetal cell per 1000 maternal cells). The volume of hemorrhage can be roughly estimated by the following formula: stained cells/unstained cells ϫ maternal blood volume ϭ FMH in whole blood (ml). A maternal blood volume of 5 l is commonly assumed in laboratory formulas so that one fetal cell per 1000 maternal cells corresponds to a hemorrhage of 5 ml of fetal whole blood.
The definition of massive FMH is arbitrary. We chose a BK value of Ն2%, which corresponds to approximately 100 ml of fetal whole blood in the maternal circulation, because this level has a clear association with fetal mortality and morbidity. Unexplained fetal death was designated when there was no condition of the fetus or mother that could reasonably cause fetal death.
Data were analyzed with a standard statistical software package by means of Student's t test and -squared analysis.
RESULTS
During the study period there was a total of 69,390 births, and 645 (0.93%) were fetal deaths weighing Ͼ500 gm. A BK test was performed in 319 (49.5%) of the fetal deaths. Fourteen of the 319 patients (4.4%) had massive FMH. One or more risk factors for FMH were present in 102 of 319 (32%). The distribution of the risk factors are shown in Table 1 .
Patients with risk factors for FMH did not differ from those without risk factors with respect to maternal age (27.
The cases of fetal death with massive FMH are summarized in Table 2 . Five of these 14 fetal deaths (36%) had a major malformation, and two cases involved the urinary tract. Fetal death was otherwise unexplained in 141 cases of whom five (3.5%) had massive FMH.
DISCUSSION
The phenomenon of fetomaternal hemorrhage was first proposed by Wiener in 1948 and later confirmed by Chown in 1954. 6 Entry of fetal blood cells into maternal circulation occurs in up to 50% of pregnancies. In only 1% of cases, however, will FMH volume exceed 40 ml. 7 Massive FMH has been variously defined as a bleed of 50 to 150 ml. 3, 5, 7 It is an important cause of fetal morbidity and mortality. In our study, 14 fetal deaths had evidence of massive FMH, an incidence of 4.4% of the 319 cases of fetal death in which the BK test was performed. The incidence of massive FMH is about 0.02% in the total population of 69,390 births. It is not known if the incidence is higher or lower because we did not test the entire cohort. Our rates of massive FMH closely approximate those of Marions et al. (0.03% of all births and 4% of all fetal deaths) 3 and Laube et al. (0.04% of all births and 3.4% of all fetal deaths). 5 Marions et al. 3 reported six patients near term whose fetuses died in association with massive FMH and concluded that the BK test should be performed in all cases of fetal death of unknown etiology. Laube et al. 5 described four cases of fetal demise associated with massive FMH (defined as greater than 150 ml) and concluded that massive FMH is an important cause of death among fetuses without other apparent causes of death. Ahlenius et al. 9 prospectively studied 66 cases of fetal death to describe the etiology of fetal death and the value of various diagnostic procedures. Four of 66 (6.1%) cases of fetal death were associated with FMH (Ͼ50 ml). They also concluded that the BK should be included in the evaluation of fetal death.
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A number of conditions have been associated with antepartum FMH, including abdominal and/or multiple trauma, amniocentesis, external cephalic version, placental tumors (chorioangiomas), preeclampsia, and other hypertension disorders, abruptio placentae, monoamniotic-monochorionic twins, twin-twin transfusion, placenta previa, and fetal death itself. 7, 8, 10 Most of these conditions involve the disruption of the maternal-fetal barrier at the level of the placenta. Whether such risk factors accurately identify the patients at risk for FMH has been questioned in studies by Ness et al. 11 and Sebring et al. 8 With regard to massive FMH, the predictive value of these risk factors has not been studied. We systematically evaluated whether or not there is an association of risk factors for FMH with fetal death apparently resulting from massive FMH. Our data suggest that one can not rely on the clinical setting to identify which patients should be tested for FMH as a cause for fetal death. Perhaps of more importance, our data suggest a previously unidentified risk factor for FMH-fetal malformations.
The association of fetal anomalies with massive FMH in 5 of 14 (35.7%) cases suggests that FMH may be one important cause for demise in the anomalous infant. Fetuses with major malformations are at increased risk for stillbirths, the mechanism(s) of which are not well understood. The anomalous fetus may provide a model to study the natural history of FMH in a well-defined population, possibly at increased risk for massive FMH. A prospective study should be undertaken to determine if the anomalous fetus has a greater risk for massive FMH.
In the vast majority of cases, the BK was drawn before the delivery of the dead fetus. Even for cases in which the BK was drawn after delivery, it reliably reflects antepartum FMH. This conclusion is based on the work of Owen et al. 12 who demonstrated that the delivery process itself does not simulate a fetomaternal hemorrhage by introducing fetal cells into the maternal circulation.
Previous studies have been limited by small sample size. Our study is one of the larger series of fetal deaths systematically evaluated for FMH. Our results indicate that patients without risk factors for FMH are just as likely as patients with known risk factors to present with fetal demise associated with massive FMH. We recommend that BK testing be performed in all cases of fetal death, including those with fetal anomalies, regardless of supposed risk factors for FMH.
